Congress trades
Integra LifeSciences Holdings Corporation (IART)
About Integra LifeSciences Holdings Corporation
from the company's filings and listing- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical - Devices
- Chief executive
- Stuart Essig
- Employees
- 4,427
- Listed since
- Aug 16, 1995
- Market value
- $1.3B
- Price to earnings
- -
- Earnings per share
- -$0.09
- Dividend yield
- -
Earnings
6 reported quarters · next on Oct 29, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q2 FY2026reported Jul 29, 2026 | $0.56 | $0.48 | $418.8M | $417.5M | EPS beatRevenue in line |
| Q1 FY2026reported May 5, 2026 | $0.54 | $0.41 | $391.9M | $381.8M | EPS beatRevenue beat |
| Q4 FY2025reported Feb 26, 2026 | $0.83 | $0.79 | $434.9M | $429.6M | EPS beatRevenue in line |
| Q3 FY2025reported Oct 30, 2025 | $0.54 | $0.43 | $402.1M | $429.6M | EPS beatRevenue miss |
| Q2 FY2025reported Jul 31, 2025 | $0.45 | $0.43 | $415.6M | $414.3M | EPS beatRevenue in line |
| Q1 FY2025reported May 5, 2025 | $0.41 | $0.43 | $382.7M | $402.6M | EPS missRevenue miss |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.
Executive pay
as filed for 2025 · proxy filed Apr 6, 2026| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| Mojdeh PoulPresident and Chief Executive Officer and Director | $1.0M | $5.2M | $3.1M | $9.4M |
| Lea KnightExecutive Vice President and Chief Financial Officer | $639K | $1.5M | $746K | $2.9M |
| Michael J. McBreenExecutive Vice President, President, Codman Specialty | $644K | $1.3M | $742K | $2.7M |
| Robert T. Davis, JrExecutive Vice President, President, Tissue Technologi | $583K | $893K | $437K | $1.9M |
| Harvinder SinghExecutive Vice President, President, International | $564K | $683K | $378K | $1.6M |
The summary compensation table from the 2025 proxy statement, current executives only. 1 executive who has since left the company is named in that filing and not shown here. Read the filing
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Change | Of company |
|---|---|---|---|---|
| Blackrock, Inc. | $191.9M | 10,684,103 | +3.5% | 13.67% |
| Rubric Capital Management LP | $139.3M | 7,753,934 | 0.0% | 9.92% |
| Invesco Ltd. | $67.3M | 3,749,367 | +7.6% | 4.80% |
| Vanguard Portfolio Management LLC | $67.2M | 3,743,093 | +1.5% | 4.79% |
| Morgan Stanley | $64.5M | 3,593,079 | +0.2% | 4.60% |
| Paradigm Capital Management Inc/Ny | $61.8M | 3,439,098 | -14.3% | 4.40% |
| Fuller & Thaler Asset Management, Inc. | $61.7M | 3,436,006 | -2.6% | 4.40% |
| State Street Corp | $52.9M | 2,946,862 | +2.1% | 3.77% |
| Vanguard Capital Management LLC | $52.9M | 2,946,173 | +1.9% | 3.77% |
| Neuberger Berman Group LLC | $42.6M | 2,364,777 | +11.8% | 3.03% |
| Dimensional Fund Advisors LP | $39.8M | 2,216,653 | -20.1% | 2.84% |
| Geode Capital Management, LLC | $32.2M | 1,791,635 | +8.1% | 2.29% |
A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.
GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.
Congress trades in IART
12 disclosures of 12 on record · median 29d of the 45 allowed| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | -44.0%S&P +39.0% · vs S&P 500 -82.9% | Jun 18, 2024 | Jul 9, 2024 | 21d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | -52.2%S&P +47.1% · vs S&P 500 -99.3% | Apr 5, 2024 | May 15, 2024 | 40d |
| Josh GottheimerJoint | Stock | Purchase | $1,001 - $15,000 | -57.7%S&P +75.0% · vs S&P 500 -132.6% | Oct 16, 2023 | Nov 11, 2023 | 26d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | -59.0%S&P +71.5% · vs S&P 500 -130.5% | Sep 15, 2023 | Oct 15, 2023 | 30d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | -60.6%S&P +74.7% · vs S&P 500 -135.3% | Jun 13, 2023 | Jul 11, 2023 | 28d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | -77.5%S&P +63.5% · vs S&P 500 -141.0% | Nov 5, 2021 | Dec 7, 2021 | 32d |
| Josh GottheimerJoint | Stock | Purchase | $1,001 - $15,000 | -66.5%S&P +119.7% · vs S&P 500 -186.2% | Oct 16, 2020 | Nov 5, 2020 | 20d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | -64.3%S&P +124.2% · vs S&P 500 -188.5% | Sep 15, 2020 | Oct 13, 2020 | 28d |
| Gilbert Ray Cisneros, Jr. | Stock | Purchase | $1,001 - $15,000 | -67.0%S&P +165.7% · vs S&P 500 -232.7% | Mar 10, 2020 | Apr 16, 2020 | 37d |
| Josh GottheimerJoint | Stock | Purchase | $1,001 - $15,000 | -70.7%S&P +135.3% · vs S&P 500 -206.0% | Feb 3, 2020 | Mar 16, 2020 | 42d |
| Gilbert Ray Cisneros, Jr. | Stock | Purchase | $1,001 - $15,000 | -72.1%S&P +127.9% · vs S&P 500 -200.0% | Feb 10, 2020 | Mar 10, 2020 | 29d |
| Thom TillisJoint | Stock | Sale (Full) | $1,001 - $15,000 | -42.9%S&P +264.3% · vs S&P 500 -307.2% | Feb 13, 2015 | Feb 26, 2015 | 13d |
Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 10, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.
Questions
Which members of Congress have traded IART?
Josh Gottheimer, Ro Khanna, Gilbert Ray Cisneros, Jr., Thom Tillis disclosed IART transactions in the filings shown here.
How quickly are IART trades disclosed?
Congressional disclosures took a median of 29 days, against the 45 the STOCK Act allows.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Sep 10, 2026.